1. Home
  2. FLGC vs PMN Comparison

FLGC vs PMN Comparison

Compare FLGC & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGC
  • PMN
  • Stock Information
  • Founded
  • FLGC 2019
  • PMN 2004
  • Country
  • FLGC United States
  • PMN Canada
  • Employees
  • FLGC N/A
  • PMN N/A
  • Industry
  • FLGC Biotechnology: Pharmaceutical Preparations
  • PMN Pharmaceuticals and Biotechnology
  • Sector
  • FLGC Health Care
  • PMN Health Care
  • Exchange
  • FLGC Nasdaq
  • PMN Nasdaq
  • Market Cap
  • FLGC 15.9M
  • PMN 16.0M
  • IPO Year
  • FLGC 2021
  • PMN N/A
  • Fundamental
  • Price
  • FLGC $0.69
  • PMN $0.40
  • Analyst Decision
  • FLGC Buy
  • PMN Strong Buy
  • Analyst Count
  • FLGC 2
  • PMN 2
  • Target Price
  • FLGC $4.00
  • PMN $4.50
  • AVG Volume (30 Days)
  • FLGC 104.1K
  • PMN 67.9K
  • Earning Date
  • FLGC 08-11-2025
  • PMN 08-07-2025
  • Dividend Yield
  • FLGC N/A
  • PMN N/A
  • EPS Growth
  • FLGC N/A
  • PMN N/A
  • EPS
  • FLGC N/A
  • PMN N/A
  • Revenue
  • FLGC $53,260,000.00
  • PMN N/A
  • Revenue This Year
  • FLGC N/A
  • PMN N/A
  • Revenue Next Year
  • FLGC N/A
  • PMN N/A
  • P/E Ratio
  • FLGC N/A
  • PMN N/A
  • Revenue Growth
  • FLGC N/A
  • PMN N/A
  • 52 Week Low
  • FLGC $0.42
  • PMN $0.38
  • 52 Week High
  • FLGC $2.11
  • PMN $2.28
  • Technical
  • Relative Strength Index (RSI)
  • FLGC 55.93
  • PMN 32.23
  • Support Level
  • FLGC $0.62
  • PMN $0.48
  • Resistance Level
  • FLGC $0.72
  • PMN $0.50
  • Average True Range (ATR)
  • FLGC 0.05
  • PMN 0.03
  • MACD
  • FLGC 0.00
  • PMN -0.01
  • Stochastic Oscillator
  • FLGC 75.00
  • PMN 18.75

About FLGC Flora Growth Corp.

Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: